Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other 1

Conditions

Osteosarcoma 2Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Radiotherapy 3Cisplatin 3Radiation 2pegfilgrastim 1hydrated silica gel-based toothpaste 1glucarpidase 1angiotensin I (1-7) 1aluminum hydroxide, magnesium hydroxide, drug combination 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Selenomethionine 1Neck Dissection 1Methotrexate 1Lidocaine 1Leucovorin 1Ketamine 1Granulocyte Colony-Stimulating Factor 1Glutamine 1Fluorouracil 1Filgrastim 1Fibroblast Growth Factor 7 1Everolimus 1Docetaxel 1Diphenhydramine 1Curcumin 1Amifostine 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Mucositis × glucarpidase × Clear all
NCT02022358 2015-06-04

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

University College, London

Phase 2 Terminated
34 enrolled
OtherSarcoma

Osteosarcoma, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡